Search results

• 2022

  Engineering of an avidity-optimized CD19-specific parallel chimeric antigen receptor that delivers dual CD28 and 4-1BB co-stimulation

  Halim, L., Das, K., Larcombe-Young, D., Ajina, A., Candelli, A., Benjamin, R., Dillon, R., Davies, D. & Maher, J., 9 Feb 2022, In: Frontiers in immunology. 13, 836549.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Co-Stimulation 100%
  • CD19 100%
  • Chimeric Antigen Receptor 100%
  • CD28 100%
  • Avidity 100%
  16 Citations (Scopus)

  214 Downloads (Pure)